Author · brief 2026-08-16

@jensklattfx

grade Bx.com/jensklattfx ↗

German-language substantive earnings analysis

de

trader score
+0.50
hit rate
65%
mean α
+0.50%
signals 14d
32

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY. · Analyst brief as of 2026-08-16.

Their picks, scored

Across their last 20 scored bets: 65% hit rate, +0.50% mean alpha, trader score +0.50. Their last-14d mentions, direction-adjusted, have moved +2.0% since posting (mean over 21 mentions with price data).

Constructive Nasdaq breakout view ahead of major retail earnings

The author is constructively calling a Nasdaq-100 breakout toward 30,500–30,600, with QQQ described as increasingly interesting. Late-week attention shifted to the upcoming WMT, BABA, and TGT earnings calendar, without directional calls or disclosed positions.

Disclosed booknames the author says they hold — positions, not commentary

No positions disclosed this window — everything below is commentary, not book talk.

Themes2analyst read · 2026-08-16
▲Nasdaq breakout and upside target
bullconsistent1 signals
QQQ
⚠ 100% of theme signals are QQQ — flag pump risk
◆Upcoming large-cap retail earnings calendar
neutralconsistent3 signals
WMTBABATGT
Hypotheses4what the author said, ticker-anchored — ✓ skin = disclosed position behind it
claimtickerdirstrengthsignalsskinthemereceipt
QQQ looks increasingly attractive as the Nasdaq-100 breaks out toward 30,500–30,600.QQQ▲0.012·Nasdaq breakout and upside targe
WMT is scheduled to report earnings next week.WMT◆0.003·Upcoming large-cap retail earnin
BABA is scheduled to report earnings next week.BABA◆0.003·Upcoming large-cap retail earnin
TGT is scheduled to report earnings next week.TGT◆0.003·Upcoming large-cap retail earnin
Direction this week

The directional view is concentrated in QQQ and the Nasdaq-100 breakout, with an upside target region of 30,500–30,600. The remaining signals flag WMT, BABA, and TGT earnings without expressing directional conviction; there are no adds, trims, exits, or position disclosures.

Per-ticker coverage24positions first, then by signal count
tickersignalssentimentcallsposnewsactionalignment
PLTR4+0.51003bullish commentarycommentary only
META4-0.19002neutral commentaryneutral
PYPL3+0.52002bullish commentarycommentary only
BTC3-0.10000neutral commentaryneutral
SPCX3-0.18001neutral commentaryneutral
AMD3+0.42001bullish commentarycommentary only
SNDK3+0.62001bullish commentarycommentary only
QCOM2-0.03002neutral commentaryneutral
ARM2+0.65001bullish commentarycommentary only
PFE2+0.58002bullish commentarycommentary only
SHOP2+0.62002bullish commentarycommentary only
DAX1+0.40000bullish commentarycommentary only
ORCL1+0.10000neutral commentaryneutral
WMT1+0.00000neutral commentaryneutral
SMCI1+0.00000neutral commentaryneutral
NVDA1-0.20000neutral commentaryneutral
BABA1+0.00000neutral commentaryneutral
NBIS1+0.00000neutral commentaryneutral
APP1+0.00000neutral commentaryneutral
QQQ1+0.30000bullish commentarycommentary only
TGT1+0.00000neutral commentaryneutral
RKLB1+0.00000neutral commentaryneutral
TTD1+0.00000neutral commentaryneutral
SE1+0.00000neutral commentaryneutral

Alignment separates skin-in-the-game from commentary: ✓ = the author discloses a position consistent with their talk; “call (no pos)” = directional call without a disclosed position; “commentary” = opinion only.

Best hypotheses4their highest-scoring claims in our index
◆Next week’s earnings are the decisive near-term test of Target’s rally and broader consumer-spending resilience.
neutralHIGH15 co-supporters
◆Walmart's August 20 Q2 earnings will be the dominant near-term catalyst and an important read on consumer spending.
neutralHIGH12 co-supporters
▲Store additions and supply-chain growth demonstrate that Domino's global expansion engine remains intact despite softer
bullMEDIUM4 co-supporters
▲Citigroup’s 11.6% dividend increase and $30B buyback materially strengthen shareholder returns and the valuation case.
bullMEDIUM2 co-supporters
Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-08-24·@JensKlattFX·Says the DAX began the trading week slowly, with details dependent on linked media.·
2026-08-21NVDA@JensKlattFX+0.00Flags four companies reporting earnings in the coming week+1.3%
2026-08-21IREN@JensKlattFX+0.00Flags four companies reporting earnings in the coming week-15.4%
2026-08-21MRVL@JensKlattFX+0.00Flags four companies reporting earnings in the coming week-8.6%
2026-08-21CRM@JensKlattFX+0.00Flags four companies reporting earnings in the coming week+22.4%
2026-08-20·@JensKlattFX·Frames small clinical-stage firms as sympathy and potential M&A candidates without explicit public tickers·
2026-08-20PFE@JensKlattFX+0.05Maps public cancer-vaccine peers, sympathy moves, clinical prospects, and M&A potential+0.6%
2026-08-20EVAX@JensKlattFX+0.50Maps public cancer-vaccine peers, sympathy moves, clinical prospects, and M&A potential·
2026-08-20MRNA@JensKlattFX+0.30Balances manufacturing and adoption risks against positive clinical validation for mRNA technology+3.5%
2026-08-20NVAX@JensKlattFX+0.10Maps public cancer-vaccine peers, sympathy moves, clinical prospects, and M&A potential+10.0%
2026-08-20BNTX@JensKlattFX-0.10Maps public cancer-vaccine peers, sympathy moves, clinical prospects, and M&A potential-7.9%
2026-08-20CVAC@JensKlattFX+0.00Maps public cancer-vaccine peers, sympathy moves, clinical prospects, and M&A potential·
2026-08-20MRNA@JensKlattFX+0.70Calls the cancer-vaccine result a major platform validation with multibillion-dollar potential+3.5%
2026-08-20MRNA@JensKlattFX+0.70Phase 3 combination trial met RFS and DMFS endpoints with no new safety signal+3.5%
2026-08-20MRK@JensKlattFX+0.50Phase 3 combination trial met RFS and DMFS endpoints with no new safety signal-0.4%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.